Skip to main content

Table 1 Summary of the studies reporting off-label medicines use and specifying respiratory off-label use

From: Off-label prescribing for allergic diseases in children

 

Off-label%

Reference

Country

Setting

Study design*

Age

No patients

No Prescriptions

Off-label type

Total

Resp.

Knopf, 2013 [17]

Germany

Population based sample (KiGGS)

Prospective; drug-use assessed by survey

0 to 17 years

8899

12667

Age, dose, indication

30

37

Morais-Almeida, 2013 [12]

Portugal

Allergy outpatient clinic

Retrospective; clinical files analysis in 2012

0 to 6 years

500

1224

Age, dose, indication

35

77

Ribeiro, 2013 [18]

Portugal

ED; University Hospital

Retrospective; random sample of children attending to the ER for 9 months in 2010

0 to 17 years

700

724

Age, dose, indication, route

32

28

Ballard, 2012 [19]

Australia

Pediatric general ward, acute-care university Hospital

Retrospective; two groups of 150 consecutive pediatric patients admitted in July 2009 and Jan. 2010

1 day to 11 years

300

887

Age, dose, indication, route

32

11

Kimland, 2012 [20]

Sweden

34 Pediatric; 7 non-Pediatric Hospitals

Prospective; data collection of all prescriptions, in two separate 48 hour periods (May and October 2008)

0 to 18 years

2947

11 294

Age, dose, indication, route

34

11

Palcevski, 2012 [21]

Croatia

Pediatric Ward; University Hospital

Prospective; clinical files analysis on a pre-determined day of each month during 12 months (May 2010 to April 2011)

0 to 19 years

531

1643

Age, indication, route

13.3

5.1

Olsson, 2011 [22]

Sweden

Population based sample (Swedish Prescribed Drug Register)

Retrospective; analysis of all outpatient prescriptions performed in 2007

0 to 18 years

--

2.19 million

Age, dose, indication

13.5

3.1

Phan, 2010 [23]

US

ED of a tertiary-care children’s Hospital

Retrospective; all medical records admissions analysis from January to May 2007

0 to 18 years

2191

6675

Age, dose, Indication, route

25.6

31.8

Morales-Carpi, 2010 [24]

Spain

Outpatient prescriptions

Prospective; analysis of all prescriptions performed prior to the ED visit collected from June2005 to August 2006 (14 months)

0 to 14 years

336

667

Indication, dose, frequency and route

50.7

31.4

  

Join outpatient prescriptions to ER random sample; University Hospital

       

MuhlBauer 2009 [25]

Germany

German statutory health insurance provider

Retrospective; analysis of all prescriptions performed during 2002

0 to 16 years

--

1.5 million

Age, indication

3.2

7

Bazzano, 2009 [26]

US

National Ambulatory Medical Care Surveys (NAMCS)

Retrospective; representative sample of outpatient visits from 2001 to 2004

0 to 18 years

312 million

484 million

Age, indication

62#

70#

Jain, 2008 [27]

India

Tertiary care central Hospital

Prospective study, prescription survey applied to a consecutive sample of children admitted to the ward from May to July 2006

1 month to 12 years

600

2064

Age, dose, frequency, indication

51

53

Hsien, 2008 [28]

Germany

Pediatric ward in tertiary care Hospital

Prospective study of all patient files between January and June 2006

0 to 18 years

417

1812

Age, dose, indication

31

30

Shah, 2007 [29]

US

31 tertiary care pediatric hospitals (PHIS database)

Retrospective study of all children discharged from the Hospital during 2004

0 to 17 years

355409

---

Age, indication

78.7#

11.2#

Ufer, 2004 [30]

Sweden

Population based sample (Statistics Sweden and the National Corporation of Swedish Pharmacists)

Retrospective study of all drug register present in the database in 2000

0 to 15 years

--

2,8million

Age, dose, indication, formulation, route

20.7

8.6

Schirm, 2003 [31]

Netherland

Pharmacies dispensing records in northern Netherland (Interaction database)

Retrospective study of all drugs dispensing records in the Interaction database in 2000

0-16 years

18493

66222

Age

20.6

15.1

Pandolfini, 2002 [32]

Italy

Nine general pediatric hospitals wards

Prospective; analysis of all prescriptions performed to children in 12 week period

1 month to 14 years

1461

4255

Dose, route, indication and duration

60

33

McIntyre, 2000 [33]

England

Suburban general practice clinic

Retrospective; study of all prescriptions performed in 1998

0 to 12 years

1175

3347

Age, dose, route

10.5

28

  1. *All studies had a cross-sectional study design; ED- Pediatric Emergency department; #- off-label percentages is reported to visits or patients that received at least 1 off-label-drug; KiGGS- German Health Interview and Examination Survey for Children and Adolescents; PHIS- Pediatric Health Information System.